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Senataxin: A Putative RNA: DNA 
Helicase Mutated in ALS4—
Emerging Mechanisms of Genome 
Stability in Motor Neurons
Arijit Dutta, Robert Hromas and Patrick Sung
Abstract
Amyotrophic lateral sclerosis type 4 (ALS4) is a rare, autosomal dominant 
childhood- or adolescent-onset motor neuron disease caused by genetic defects in 
senataxin (SETX), a putative RNA–DNA helicase. Studies on the yeast SETX ortho-
log Sen1 revealed its role in small RNA termination pathways. It has been postulated 
that ALS4-associated neuronal pathologies could stem from defects in RNA metab-
olism and altered gene expression. Importantly, SETX prevents the accumulation of 
R-loops, which are potentially pathogenic RNA–DNA hybrids that stem from per-
turbations in transcription. SETX also interacts with the tumor suppressor BRCA1 
that helps promote DNA double-strand break repair by homologous recombination. 
As such, SETX could contribute toward the removal of harmful R-loops and DSBs 
in postmitotic neurons. This chapter will visit the plausible mechanistic role of 
SETX in R-loop removal and DNA break repair that could prevent the activation of 
apoptotic cell death in neurons and pathological manifestation of ALS4.
Keywords: spinal muscular atrophy, SETX, transcription, R-loop,  
DNA double-strand break, homologous recombination,  
nonhomologous DNA end joining
1. Introduction
Amyotrophic lateral sclerosis (ALS) type 4 is a rare form of distal spinal muscu-
lar atrophy (SMA) with onset at age 25 years or younger. The disease first manifests 
itself with weakness of ankles and wrists and gradually paralyzes the limbs due to 
severe muscle wasting. However, unlike classical ALS, the respiratory and bulbar 
muscles, sensory abilities, and cognitive functions are largely preserved in ALS4 
patients. Hence, ALS4 patients, while having to endure severe disabilities, could 
expect an otherwise normal life expectancy with proper medical attention.
In 1998, the joint effort of Phillip Chance and David Cornblath described the 
Mattingly disease, a hereditary peripheral neuropathy as ALS type 4 (ALS4) [1]. 
The Mattingly disease was first seen among the descendants of a seventeenth-
century English colonist, Thomas Mattingly from Maryland. With collaborations 
of the Mattingly clan, the work of Chance and Cornblath led to the identification 
of the disease gene locus located at chromosome 9q34 [1]. The causative gene was 
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identified to be Senataxin (SETX), which is a large protein with features that typify 
RNA–DNA helicases [2]. Three distinct mutations in SETX were found in pedigree 
analysis of ALS4 patients. Some later studies also reported sporadic mutations in 
SETX [3, 4], which are summarized in Table 1. It should be noted that the other 
three forms of juvenile ALS (JALS) stem from mutations in different genes, namely, 
ALS2 (ALS2), SPG11 (ALS5), and SIGMAR1 (ALS16).
Pathological studies of ALS4 have been hampered because of the rarity of the 
disease, with only about a dozen of diagnosed families around the world. Chen 
et al. [2] detected degeneration of anterior horn cells in spinal cords and cortico-
spinal tracts in postmortem tissues from two aged individuals of pedigree K7000. 
Specifically, even though sensory abilities were not significantly affected in these 
individuals, a significant loss of dorsal root ganglia and posterior columns was 
detected, along with marked axonal degeneration of motor and sensory roots and 
peripheral nerves.
In another study, cytosolic mislocalization of the transactive response DNA-
binding protein (TDP-43) was observed in spinal cord motor neurons in postmor-
tem tissues from all the ALS4 patients examined [8]. TDP-43 is an RNA metabolism 
factor and is a well-documented biomarker that forms toxic protein aggregates in 
multiple neurodegenerative diseases including ALS [9, 10]. Recapitulation of TDP-43 
histopathology in motor neurons of mice carrying ALS4 mutations led the authors to 
imply that dysfunction of SETX converges on TDP-43 pathology causing an ALS-
type motor neurodegeneration [8], although the mechanism was not identified.
SETX has also been found mutated in another neurodegenerative disorder termed 
ataxia with oculomotor apraxia type 2 (AOA2) [11]. However, in this case, disease is 
caused by missense mutations leading to premature termination of the SETX mRNA 
transcript. AOA2 patients suffer from progressive cerebellar ataxia with peripheral 
neuropathy, cerebellar atrophy, and occasional oculomotor apraxia. However, unlike 
in ALS4, the motor neuron functions are largely preserved in AOA2 patients [12]. It 
has been suggested that distinct pathologies of AOA2 and ALS4 stem from unique 
alterations in expression of genes regulated via SETX in neuronal cells [13].
In spite of the seminal discovery of SETX mutations as being the root cause 
of ALS4, the etiopathogenesis of this disease remains largely unknown. In this 
Mutation Amino acid 
substitution
Family 
history
Origin References
c.8C → T T3I Positive Austria Chen et al. [2]
c.1166T → C L389S Positive
Positive
United 
States
Italy
Rabin et al. [5]
Chen et al. [2]
Avemaria et al. [6]
c.2672T → T V891A Positive Germany Rudnik-Schoneborn et al. [7]
c.4660T → G C1554G Negative United 
States
Hirano et al. [3]
c.6085C → G K2029Q Negative United 
States
Hirano et al. [3]
c.6407G → A R2136H Positive Belgium Chen et al. 2004 [2]
c.6406C → T R2136C Negative Japan Saiga T et al., 2012 [4]
c.7640T → C I2547T Negative United 
States
Hirano et al. [3]
Table 1. 
ALS4-associated mutations in SETX.
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chapter we will consider the properties of SETX and its role in the maintenance of 
genomic stability that are likely germane for the health of motor neurons and ALS4 
pathology.
2. Senataxin at the crossroads of RNA metabolism and genomic stability
Studies on SETX predate its ALS4 association. SETX is the likely ortholog of 
a budding yeast protein, splicing endonuclease 1 (Sen1), so named because of its 
suspected role in the endonucleolytic processing of tRNA during its splicing and 
maturation [14]. However, because Sen1 lacks endonuclease activity, it likely func-
tions as a non-catalytic effecter of the nucleolytic entity within the splicing machin-
ery [15]. Sen1 possesses sequence motifs characteristic of superfamily 1 (SF1B) 
nucleic acid helicases [16]. Consistent with this, Sen1 possesses a helicase activity 
capable of unwinding RNA-DNA hybrids [17–19]. Like other SF1B helicases, Sen1 
translocates on nucleic acid strands in the 5′ → 3′ direction [20].
SETX is of low abundance (<500 molecules/cell) predominantly a nuclear 
protein with some studies reporting its presence in the nucleolus [21, 22]. SETX 
interacts with RNA polymerase II (pol II) and helps ensure correct termination 
of transcription and, as such, is important for the processing of noncoding RNAs 
(ncRNAs) and mRNAs [23, 24]. Importantly, recent studies suggest a role of SETX 
in maintaining genomic stability across highly transcribed genomic regions via 
resolution of RNA–DNA hybrids called R-loops, which arise as a consequence 
of RNA pol II stalling or perturbations of a transcription-coupled process such 
as mRNA splicing [25]. Moreover, SETX could also clear RNA–DNA hybrids at 
genomic breaks and promote DNA repair via homologous recombination (HR) 
[26]. We will explore the various functions of SETX/Sen1 and possible mechanisms 
by which SETX mutations give rise to ALS4.
2.1 Biochemical and structural features of SETX
SETX is a large protein of 2677 amino acid residues (303 kDa) and, like yeast 
Sen1, harbors SF1B-type helicase motifs (Figure 1A). It should be noted that even 
though Sen1 is known to unwind RNA-DNA hybrids [14, 15], such an activity has 
not yet been demonstrated for SETX. However, ALS4-associated missense muta-
tions (K2029Q , R2136H, and I2547T) are all located in the putative C-terminal heli-
case domain of SETX (Figure 1A). Both SETX and Sen1 have an N-terminal domain 
that undergoes SUMO modification (Figure 1A) and that mediates protein–protein 
interactions with factors that function in RNA metabolism [27]. SETX likely forms 
a homodimer via the N-terminal domain, but the hereditary ALS4 mutations do not 
appear to affect protein dimerization [28].
2.1.1 SETX has a large intrinsically disordered region (IDR)
In silico analysis suggests that there is a large IDR in SETX that spans more than 
1000 amino acid residues, a structural feature that is absent in the yeast ortholog 
Sen1. This putative IDR could confer to SETX the ability to interact with different 
protein partners, to bind nucleic acids [29]. IDRs in nucleic acid-binding proteins 
are often subject to post-translational modifications and could undergo phase sepa-
ration, a molecular phenomenon of rearrangement of molecules in a homogenous 
solution into distinctly concentrated regions of space called condensates [30–33]. 
However, unrestrained phase separation causes protein aggregation that is observed 
with FUS [34] and TDP-43 [35], two extensively studied factors associated with 
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Figure 1. 
(A) Schematic diagram of SETX, indicating N-terminal domain (green), central domain (red), and 
C-terminal helicase domain (blue); conserved motifs are highlighted: Motif I interacts with Mg2+ and NTP, 
conserved G maintains a flexible loop, motif 1a binds with substrate nucleic acid and transduces energy from 
the ATP-binding site to the DNA-binding site, motif II binds and hydrolyses ATP, motif III couples ATP 
hydrolysis with helicase activity, motif V binds substrate nucleic acid, and motif VI couples ATP hydrolysis 
with helicase activity; ALS4 mutation residues (red) are T3I, L389S, V891A, C1554G, K2029Q , R1236H/C, 
and I2647T; predicted sumoylation residues (blue) are K78, K863, and K1051 [119]; and cysteine residues 
predicted by CYSPRED (reliability≥8) to form disulfide bonds (indicated by stars) are C4, C5, C7, C145, 
C555, C637, C688, C997, C1080, C1123C,1153, C1262, C1277, C1398, C1442, C1509, C1672, C1719, and C2622. 
(B) Prediction of natural disordered region of SETX (upper panel), and Sen1 (lower panel), with the in silico 
metapredictor PONDR-VL3 [120]. N-terminal domain (green), central disordered region (red), C-terminal 
helicase domain (blue).
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ALS, which are known to form stress granules in diseased neurons. It could be that 
SETX, through a phase separation mechanism, forms macromolecular complexes 
with factors associated with transcription and DNA damage repair. Pathological 
mutations in SETX could then lead to protein aggregation and loss of protein func-
tion in ALS4. This premise awaits experimental testing.
2.1.2 SETX structure could be regulated via disulfide bonding
Multiple neurodegenerative diseases including ALS have been classified among 
protein misfolding disorders, with disruption of protein disulfide isomerases (PDIs) 
causing aggregation of superoxide dismutase (SOD1) and TDP-43 in ALS neurons 
[36]. PDIs are a family of proteins that catalyze formation of disulfide bonds and 
proper folding of proteins, particularly especially those that harbor an IDR [37]. 
SETX has 31 cysteine residues in its IDR, and in silico analysis of this region using 
two independent neural network based predictors, CYSPRED [38] and DIpro [39], 
revealed that at least 14 cysteine residues in the SETX IDR could engage in disulfide 
bonding (Figure 1A), which is expected to be catalyzed by a PDI. This notion is 
supported by a proteomic analysis where PDIA6 was detected as a component of the 
SETX-interactome (Figure 2), [40]. We also note that amino acid residue C1554, 
expected to engage in disulfide linkage with C1509 (Figure 1A), is mutated in a 
sporadic case of ALS4 [3]. Testing of SETX regulation via redox homeostasis [41, 42] 
merits the effort of ALS researchers.
2.2 Involvement of SETX in RNA metabolism
2.2.1 Role in transcription termination
The role of SETX in regulation of coding and noncoding transcripts is highly 
conserved. RNA-seq analysis showed that SETX mutations that cause either 
ALS4 or AOA2 induce unique changes in gene expression patterns [13]. Studies in 
yeast have shown that Sen1 interacts directly with RNA pol II and is an integral 
component of the transcription termination machinery consisting of two other 
Figure 2. 
SETX interactome: DNA repair factors (red), sumoylation and ubiquitination-associated factors (purple), 
RNA exosome factors (blue), RNAP II and transcription-associated factors (orange), splicing factor and RNA-
binding proteins (green), adapted from [40].
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factors (Nrd1 and Nab3) that regulate the generation of small nuclear RNAs 
(snRNAs) and small nucleolar RNAs (snoRNAs) [43–45]. During aberrant RNA 
pol II pausing, the Nrd1-Nab3-Sen1 (NNS) complex is recruited via direct interac-
tion of Sen1 and Nrd1 with the C-terminal domain (CTD) of RNA pol II [46, 47]. 
Moreover, Pcf11, a component of the cleavage and polyadenylation complex 
(CPAC), facilitates RNA pol II CTD Ser2 phosphorylation and handoff of Sen1 
from the NNS complex to RNA pol II [48]. NNS complex also captures polyad-
enylated RNAs and channels them to the RNA exosome complex for degradation, 
which we will discuss further in Section 2.2.2 [49]. Sen1 is also necessary for 
recruitment of Rat1/Xrn2, a 5′ → 3′ exoribonuclease at G-rich RNA pol II pause 
sites for degradation of the nascent transcripts and to prevent the accumulation 
of pathogenic R-loops [18, 50, 51]. Human lymphoblastoid and fibroblast cells 
with loss of both SETX or XRN2 result in increased R-loops and DNA double-
strand breaks (DSBs) at transcriptional pause sites and hypersensitivity of cells to 
replications of stress and DNA damage induced by ionizing radiation, ultraviolet 
light, and oxidative stress [52, 53], which will be discussed further in Section 
2.3.3. Thus, defects in pathways of RNA metabolism can lead to the induction of 
DNA damage.
2.2.2 Role in RNA surveillance machinery
SETX interacts with the RNA exosome, a highly conserved multiprotein ribo-
nuclease complex that processes or degrades a diverse spectrum of RNAs in cells 
[54]. The exosome removes improperly processed coding and noncoding RNAs 
(ncRNAs) in the nucleus and regulates mRNA turnover in the cytoplasm. Other 
critical functions of the exosome include generation of mature ribosomal RNAs, 
processing of ncRNAs into snRNAs and snoRNAs, and turnover of tRNAs. The 
human RNA exosome is a ten-subunit complex with a central six-subunit core 
that constitutes a channel (EXOSC4–9), a three-subunit cap (EXOSC1–3) and a 
ribonuclease (EXOSC11) subunit located at the bottom of the channel. The nuclear 
form of the exosome also harbors a riboexonuclease subunit, EXOSC10 [54, 55]. The 
current model posits that a RNA strand enters the exosome through the cap and is 
threaded through the channel to be fed to the ribonuclease module for nucleolytic 
processing [55].
Importantly, SETX interacts with EXOSC9, and complex formation requires 
SUMOylation of the N-terminal domain of SETX [27]. It has been inferred that 
SETX-exosome interaction reflects a vital mechanistic axis for resolving co-tran-
scriptional R-loops and preventing genomic instability at heavily transcribed regions 
in neurons. It might also be surmised that the RNA exosome is recruited via SETX 
at R-loops to help resolve these pathogenic structures via degradation of the RNA 
moiety.
Interestingly, the RNA exosome has also been linked to spinal SMA-type 
neuropathies. Familial missense mutations in EXOSC3 [56] and EXOSC8 [57] 
are linked to an infantile neuronal disorder, pontocerebellar hypoplasia type 
1 (PCH1), that is marked by cerebellar atrophy and progressive microcephaly 
along with developmental defects and degeneration of spinal motor neurons. 
Hereditary mutations in EXOSC10 also cause similar neurological defects [58]. 
Taken together, the available evidence points to a critical role of the exosome in 
the avoidance of motor neuropathies. Given the interaction noted for SETX and 
exosome, it might be contemplated that an R-loop removal defect in spinal motor 
neuronal precursor and differentiated cells could represent the underlying basis 
for PCH1.
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2.3  SETX: a guardian of genomic stability across highly transcribed genomic 
landscapes
2.3.1 Transcription-coupled (TC) repair
Nucleotide excision repair (NER) is a conserved DNA repair pathway that 
removes bulky DNA lesions such as those induced by ultraviolet light. When the 
RNA polymerase II ensemble is obstructed by such a bulky lesion, Cockayne syn-
drome B (CSB) protein, which interacts with RNA pol II, mediates the recruitment 
of NER factors such as the Cockayne syndrome A (CSA)-E3-ubiquitin ligase com-
plex [59] and the endonucleases ERCC1-XPF and XPG to mediate the removal of 
the DNA lesion. In yeast cells, Sen1 has been shown to play a direct role in TC-NER 
via interaction with Rad2, the yeast XPG ortholog [47]. Whether SETX also func-
tions in TC-NER in humans remains an open question. However, in the absence of 
SETX, the TC-NER endonucleases XPF and XPG generate DSBs at R-loops, lead-
ing to the activation of DNA damage response pathways and repair via HR or the 
alternate DSB repair pathway of nonhomologous DNA end joining (NHEJ) [60].
2.3.2 Resolution of R-loops
R-loops are RNA–DNA hybrid structures with a displaced single DNA strand 
and are generated upon reannealing of a nascent transcript with the sense strand 
[61]. R-loops are transiently formed in many regions of the genome, including 
those transcribed by RNA pol I, II, and III [62]. R-loops are abundant at promoters 
of RNA pol II-transcribed genes [63–65], at sequences that are prone to form-
ing G-quadruplex or hairpin structures in the non-template DNA strand [66]. 
Perturbations of transcription-coupled processes, such as mRNA splicing, also 
result in R-loop formation [61, 67]. R-loops are detected in the genome via DNA–
RNA immunoprecipitation (DRIP) [68] and immunofluorescence assays with the 
monoclonal antibody S9.6, which has high affinity for RNA–DNA hybrids [69]. 
Typically, to ensure that the signal detected is specific for RNA–DNA hybrids, one 
would include the expression of RNase H in cells (to digest the hybrids) or pretreat 
samples for sequencing with this enzyme.
Depending upon their location and size, R-loops could impart beneficial or 
harmful effects. R-loops could extend from a few hundred base pairs to kilo base 
pairs in size. In immunoglobulin (Ig) class switch regions, R-loops serve an impor-
tant role in Ig class switch recombination by promoting the induction of DNA 
breaks via the action of activation-induced cytidine deaminase (AID) and base exci-
sion repair factors [70]. R-loops also prime DNA replication in the mitochondrial 
genome [71]. In human fibroblast cells, R-loops can influence the expression of over 
1200 genes by facilitating transcription via suppression of DNA methylation [72] 
and recruitment or eviction of chromatin remodeling complexes [73]. On the con-
trary, R-loops could interfere with transcription at certain genomic loci like rDNA 
[62, 74]. The major threat from unscheduled R-loops is the generation of lethal DSBs 
because of head-on collisions with the DNA replication machinery [75, 76].
Because of the potential harm that R-loops could cause, their levels are tightly regu-
lated via a variety of mechanisms. In this regard, RNAseH1/2 provides a major means for 
R-loop clearance via ribonucleolytic cleavage of RNA strand [77, 78]. While topoisomer-
ase I prevents R-loop formation by reducing negative supercoiling behind the elongating 
RNA pol II, TRanscription EXport (TREX) complex factors (THOC1–7, UAP56) and 
serine−/arginine-rich splicing factor 1 (SRSF1) suppress R-loops by removing the 
nascent mRNA [79]. RNA biogenesis factors like Trf4/Air2/Mtr4p polyadenylation 
Amyotrophic Lateral Sclerosis - Recent Advances and Therapeutic Challenges
8
(TRAMP) complex and, as discussed earlier, the RNA exosome complex also participate 
in the regulation of R-loop formation or removal [80]. Moreover, R-loops can be dissoci-
ated via the nucleic acid unwinding activity of Sen1/SETX [23, 50, 81] and other helicase 
proteins such as Pif1 [82], DEAH box protein 9 (DHX9) [83], and Fanconi Anemia 
Complementation factor M (FANCM) [84]. It seems reasonable to postulate that each of 
the above-named factors operates at specific genomic milieu.
Studies so forth have suggested that SETX is involved in resolving R-loops at 
paused transcription sites [50] via forming a physiological complex with the tumor 
suppressor protein BRCA1 to prevent R-loop-associated DNA damage [25]. This 
warrants further investigation on SETX-BRCA1 axis to reveal the molecular mecha-
nisms of R-loop resolution.
2.3.3 DNA double-strand break repair and replication fork stability
Occurrence of DSBs and their repair in terminally differentiated neurons were 
reported in the early 1970s [85, 86]. Recent studies have provided evidence that ALS 
is associated with a defect in DSB repair [87–89]. DSBs are generated in neurons via 
endogenous oxidative stress [90, 91] or a topoisomerase IIβ-dependent mechanism 
that is essential for expression of early genes regulating vital neuronal functions 
[92]. A recent study showed that neuronal cells from SMA express only low levels 
of SETX and DNA-PKcs, a highly conserved NHEJ factor. As a result, SMA neurons 
display higher levels of R-loops that culminate DSB formation, and cellular toxicity 
[93]. Importantly, these phenotypic manifestations can be corrected by the overex-
pression of SETX. These observations aptly underscore the genome protective role 
of SETX in neurons.
Importantly, SETX colocalizes at DSBs with various factors that function in the 
DNA damage response and repair factors, including γH2AX, 53BP1, and BRCA1, 
and it forms a co-immunoprecipitable complex with DNA-PKcs, MRE11, RAD50 
[24, 25, 53, 94]. AOA2-pateint derived lymphoblastoid cell lines lacking SETX are 
sensitive toward topoisomerase I inhibitor, camptothecin, DNA crosslinking agent 
mitomycin C and hydrogen peroxide [53], again indicative of a role of SETX in 
the DNA damage response. Moreover, Setx−/− mice displays a defect in germ cell 
maturation due to defective meiotic recombination with unrepaired DSBs [81]. 
Interestingly, recent findings revealed that nascent transcripts or small ncRNAs 
could accumulate at DSBs via diverse mechanisms, and affect DSB repair via 
distinct pathways of HR or NHEJ [95–103]. This was further evidenced by the stud-
ies demonstrating that both excess removal and impaired clearance of RNA–DNA 
hybrids result in defective DSB repair [100], suggesting the role of RNA in DSB 
repair via processes that are yet to be characterized. In this context, SETX has been 
implicated in enhancing HR-mediated DSB repair that is catalyzed by the recom-
binase RAD51, via resolving RNA–DNA hybrids at DSBs [26]. Further biochemical 
investigations are required to dissect the mechanistic underpinnings of this process.
It should be noted that cycling cells face an incessant threat of genomic instabil-
ity via replication-transcription collisions, wherein the replication and transcrip-
tion machineries could engage in head-on collisions [104]. This could directly lead 
to formation of DSBs [76]. Importantly, SETX associates with DNA replication 
forks and promotes their progression across RNA pol II transcribed regions, a func-
tion that appears to be independent of its transcription termination role [105].
2.3.4 Telomere maintenance
Telomeres, which comprise repetitive DNA sequences, cap the ends of each 
chromosome, and their attrition leads to cellular senescence. Telomerase reverse 
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transcriptase (TERT), the catalytic subunit of telomerase that maintains the normal 
length of telomeres, is present at a low level in most differentiated cells including 
neurons [106]. TERT levels appear to be significantly lower in the spinal cord tissues 
of ALS patients than healthy individuals [107]. Ex vivo studies have suggested that 
while telomere damage induces neuronal cell death [108], the activation of telomer-
ase can enhance neuronal cell viability [109, 110]. Interestingly, a novel compound 
that enhances telomerase activity in neurons also appears to ameliorate the symp-
toms of ALS [109].
Importantly, SETX is present at telomeres, and AOA2 lymphocytes and lympho-
blasts showed reduced telomere length along with higher sensitivity toward oxida-
tive stress and DNA-damaging agents [111]. Another study has implicated SETX 
in the maintenance of telomeres in Myotis bats [112]. These observations should 
constitute the basis for investigating the mechanistic role of SETX in telomere 
maintenance in motor neurons and other cell types.
3. Conclusion
Defects in RNA metabolism factors have been associated with multiple motor 
neuron diseases including ALS and SMA [113, 114]. Despite having distinctive 
pathological manifestations and clinical onsets, such motor neuropathies could 
stem from related underlying mechanisms pertaining to RNA homeostasis. In 
this chapter, we reviewed how defective RNA metabolic pathways could ensue 
genomic instability, an emerging mechanism in neurodegenerative diseases. Co-
transcriptional R-loops are crucial for regulating gene expression in both dividing 
and postmitotic neurons; however, when not timely resolved, it will lead to genomic 
instability via generation of DNA strand breaks. While replication-transcription 
conflicts are the major source of R-loop-induced DSBs in dividing cells that need 
repair via HR or NHEJ, how R-loops trigger DSBs in postmitotic neurons remains 
to be investigated. Moreover, small RNAs at DSBs could impede repair and must 
be cleared nucleolytically or via unwinding of RNA–DNA hybrids. Genetic and 
cell-based studies of human SETX, together with biochemical characterization 
of its yeast ortholog Sen1, have suggested that SETX protects genomic stability 
via resolution of R-loops, assisting replication fork progression across transcrib-
ing genomic regions and promoting HR at DSBs. In the light of recent findings on 
implication of genomic instability in neurodegenerative diseases, as reviewed in 
[115–118], in-depth studies are required to precisely delineate role of SETX in ALS4. 
Thus, it is apposite to test if ALS4 gain-of-function mutations affect SETX activities 
pertaining to DSB repair.
Treatment of ALS4 or other JALS is currently limited to physical and occupa-
tional therapies to promote mobility and independence. While an FDA-approved 
glutamate inhibitor drug, riluzole, that slows down symptoms and prolongs sur-
vival is used clinically to treat ALS, there are currently no specific treatment for 
juvenile ALS diseases. Further studies are obligatory to recognize SETX as a thera-
peutic target for treatment of ALS4.
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